Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2006 3
2007 3
2008 6
2009 7
2010 3
2011 3
2012 7
2013 8
2014 6
2015 12
2016 15
2017 25
2018 19
2019 18
2020 23
2021 18
2022 12
2023 14
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Safety and Survival Outcomes of 177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior 223Ra treatment: The RALU Study.
Rahbar K, Essler M, Pabst KM, Eiber M, Fougère C, Prasad V, Rassek P, Hasa E, Dittmann H, Bundschuh RA, Fendler WP, Kurtinecz M, Schmall A, Verholen F, Sartor O. Rahbar K, et al. Among authors: essler m. J Nucl Med. 2023 Apr;64(4):574-578. doi: 10.2967/jnumed.122.264456. Epub 2022 Oct 27. J Nucl Med. 2023. PMID: 36302656 Free PMC article.
Reply to Bingzhi Wang, Huan Deng, and Lan Cao's Letter to the Editor re: Hojjat Ahmadzadehfar, Markus Essler. Prostate-specific Membrane Antigen Imaging: A Game Changer in Prostate Cancer Diagnosis and Therapy Planning. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.02.028: Despite its Slightly Limited Specificity, Prostate-specific Membrane Antigen Imaging is Still a Game Changer in Prostate Cancer Diagnosis and Therapy Planning.
Ahmadzadehfar H, Essler M. Ahmadzadehfar H, et al. Among authors: essler m. Eur Urol. 2019 Nov;76(5):e126-e127. doi: 10.1016/j.eururo.2019.05.028. Eur Urol. 2019. PMID: 31151676 No abstract available.
Theranostics in nuclear medicine practice.
Yordanova A, Eppard E, Kürpig S, Bundschuh RA, Schönberger S, Gonzalez-Carmona M, Feldmann G, Ahmadzadehfar H, Essler M. Yordanova A, et al. Among authors: essler m. Onco Targets Ther. 2017 Oct 3;10:4821-4828. doi: 10.2147/OTT.S140671. eCollection 2017. Onco Targets Ther. 2017. PMID: 29042793 Free PMC article. Review.
Radiolabeling Strategies of Nanobodies for Imaging Applications.
Küppers J, Kürpig S, Bundschuh RA, Essler M, Lütje S. Küppers J, et al. Among authors: essler m. Diagnostics (Basel). 2021 Aug 25;11(9):1530. doi: 10.3390/diagnostics11091530. Diagnostics (Basel). 2021. PMID: 34573872 Free PMC article. Review.
Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy.
Barca C, Griessinger CM, Faust A, Depke D, Essler M, Windhorst AD, Devoogdt N, Brindle KM, Schäfers M, Zinnhardt B, Jacobs AH. Barca C, et al. Among authors: essler m. Pharmaceuticals (Basel). 2021 Dec 22;15(1):13. doi: 10.3390/ph15010013. Pharmaceuticals (Basel). 2021. PMID: 35056071 Free PMC article. Review.
183 results